ILLUMINA, INC. — Director's Dealing 2017

Feb 17, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ILLUMINA INC (ILMN)
CIK: 0001110803
Period of Report: 2017-01-26

Reporting Person: Hampton Malcolm Garret (EVP Clinical Genomics Group)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3533	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Performance Shares	$	2019-12-29	Common Stock (10598)		Direct

Footnotes

F1: Grant of restricted stock units that vests as follows: 25% of the shares subject to the award become vested on January 9, 2018, January 9, 2019, January 9, 2020 and January 9, 2021, subject to awardee's continuing to be a service provider on such dates.

F2: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2019. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 29, 2019, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.